Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Frailty Models for Familial Risk with Application to Breast Cancer.

Gorfine M, Hsu L, Parmigiani G.

J Am Stat Assoc. 2013 Dec 1;108(504):1205-1215.

PMID:
24678132
[PubMed]
2.

Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry.

Nanda R, Schumm LP, Cummings S, Fackenthal JD, Sveen L, Ademuyiwa F, Cobleigh M, Esserman L, Lindor NM, Neuhausen SL, Olopade OI.

JAMA. 2005 Oct 19;294(15):1925-33.

PMID:
16234499
[PubMed - indexed for MEDLINE]
3.
4.

BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families.

Antoniou AC, Durocher F, Smith P, Simard J, Easton DF; INHERIT BRCAs program members.

Breast Cancer Res. 2006;8(1):R3. Epub 2005 Dec 12.

PMID:
16417652
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Association and aggregation analysis using kin-cohort designs with applications to genotype and family history data from the Washington Ashkenazi Study.

Chatterjee N, Shih J, Hartge P, Brody L, Tucker M, Wacholder S.

Genet Epidemiol. 2001 Sep;21(2):123-38.

PMID:
11507721
[PubMed - indexed for MEDLINE]
6.

Evaluating the performance of models for predicting the BRCA germline mutations in Han Chinese familial breast cancer patients.

Rao NY, Hu Z, Yu JM, Li WF, Zhang B, Su FX, Wu J, Shen ZZ, Huang W, Shao ZM.

Breast Cancer Res Treat. 2009 Aug;116(3):563-70. doi: 10.1007/s10549-008-0181-4. Epub 2008 Sep 19.

PMID:
18807178
[PubMed - indexed for MEDLINE]
7.

Evaluating the performance of the breast cancer genetic risk models BOADICEA, IBIS, BRCAPRO and Claus for predicting BRCA1/2 mutation carrier probabilities: a study based on 7352 families from the German Hereditary Breast and Ovarian Cancer Consortium.

Fischer C, Kuchenbäcker K, Engel C, Zachariae S, Rhiem K, Meindl A, Rahner N, Dikow N, Plendl H, Debatin I, Grimm T, Gadzicki D, Flöttmann R, Horvath J, Schröck E, Stock F, Schäfer D, Schwaab I, Kartsonaki C, Mavaddat N, Schlegelberger B, Antoniou AC, Schmutzler R; German Consortium for Hereditary Breast and Ovarian Cancer.

J Med Genet. 2013 Jun;50(6):360-7. doi: 10.1136/jmedgenet-2012-101415. Epub 2013 Apr 6.

PMID:
23564750
[PubMed - indexed for MEDLINE]
8.

After BRCA1 and BRCA2-what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer.

Cui J, Antoniou AC, Dite GS, Southey MC, Venter DJ, Easton DF, Giles GG, McCredie MR, Hopper JL.

Am J Hum Genet. 2001 Feb;68(2):420-31. Epub 2000 Dec 27.

PMID:
11133358
[PubMed - indexed for MEDLINE]
Free PMC Article
9.
10.

Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.

Satagopan JM, Boyd J, Kauff ND, Robson M, Scheuer L, Narod S, Offit K.

Clin Cancer Res. 2002 Dec;8(12):3776-81.

PMID:
12473589
[PubMed - indexed for MEDLINE]
Free Article
11.

Probability estimation models for prediction of BRCA1 and BRCA2 mutation carriers: COS compares favourably with other models.

Roudgari H, Miedzybrodzka ZH, Haites NE.

Fam Cancer. 2008;7(3):199-212. Epub 2007 Dec 21.

PMID:
18097771
[PubMed - indexed for MEDLINE]
12.

Application of BRCA1 and BRCA2 mutation carrier prediction models in breast and/or ovarian cancer families of French Canadian descent.

Oros KK, Ghadirian P, Maugard CM, Perret C, Paredes Y, Mes-Masson AM, Foulkes WD, Provencher D, Tonin PN.

Clin Genet. 2006 Oct;70(4):320-9.

PMID:
16965326
[PubMed - indexed for MEDLINE]
13.

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.

Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjäkoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF.

Am J Hum Genet. 2003 May;72(5):1117-30. Epub 2003 Apr 3. Erratum in: Am J Hum Genet. 2003 Sep;73(3):709.

PMID:
12677558
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes.

Antoniou AC, Pharoah PD, McMullan G, Day NE, Stratton MR, Peto J, Ponder BJ, Easton DF.

Br J Cancer. 2002 Jan 7;86(1):76-83.

PMID:
11857015
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Pre-test prediction models of BRCA1 or BRCA2 mutation in breast/ovarian families attending familial cancer clinics.

de la Hoya M, Díez O, Pérez-Segura P, Godino J, Fernández JM, Sanz J, Alonso C, Baiget M, Díaz-Rubio E, Caldés T.

J Med Genet. 2003 Jul;40(7):503-10.

PMID:
12843322
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.

Satagopan JM, Offit K, Foulkes W, Robson ME, Wacholder S, Eng CM, Karp SE, Begg CB.

Cancer Epidemiol Biomarkers Prev. 2001 May;10(5):467-73.

PMID:
11352856
[PubMed - indexed for MEDLINE]
Free Article
17.

Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population.

Simchoni S, Friedman E, Kaufman B, Gershoni-Baruch R, Orr-Urtreger A, Kedar-Barnes I, Shiri-Sverdlov R, Dagan E, Tsabari S, Shohat M, Catane R, King MC, Lahad A, Levy-Lahad E.

Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3770-4. Epub 2006 Feb 28.

PMID:
16537453
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Evaluation of the BOADICEA risk assessment model in women with a family history of breast cancer.

Ståhlbom AK, Johansson H, Liljegren A, von Wachenfeldt A, Arver B.

Fam Cancer. 2012 Mar;11(1):33-40. doi: 10.1007/s10689-011-9495-1.

PMID:
22124624
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Limited family structure and BRCA gene mutation status in single cases of breast cancer.

Weitzel JN, Lagos VI, Cullinane CA, Gambol PJ, Culver JO, Blazer KR, Palomares MR, Lowstuter KJ, MacDonald DJ.

JAMA. 2007 Jun 20;297(23):2587-95.

PMID:
17579227
[PubMed - indexed for MEDLINE]
20.

Predicting BRCA1 and BRCA2 gene mutation carriers: comparison of LAMBDA, BRCAPRO, Myriad II, and modified Couch models.

Lindor NM, Lindor RA, Apicella C, Dowty JG, Ashley A, Hunt K, Mincey BA, Wilson M, Smith MC, Hopper JL.

Fam Cancer. 2007;6(4):473-82. Epub 2007 Jul 17.

PMID:
17636425
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk